Stryker Corp (SYK)
326.00
-10.50
(-3.12%)
USD |
NYSE |
May 01, 12:58
Stryker Cash and Short Term Investments (Quarterly): 3.053B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.053B |
September 30, 2023 | 1.936B |
June 30, 2023 | 1.478B |
March 31, 2023 | 1.757B |
December 31, 2022 | 1.928B |
September 30, 2022 | 1.497B |
June 30, 2022 | 1.127B |
March 31, 2022 | 1.53B |
December 31, 2021 | 3.019B |
September 30, 2021 | 2.639B |
June 30, 2021 | 2.325B |
March 31, 2021 | 2.312B |
December 31, 2020 | 3.024B |
September 30, 2020 | 7.161B |
June 30, 2020 | 6.619B |
March 31, 2020 | 4.048B |
December 31, 2019 | 4.425B |
September 30, 2019 | 2.036B |
June 30, 2019 | 1.839B |
March 31, 2019 | 1.758B |
December 31, 2018 | 3.699B |
September 30, 2018 | 2.21B |
June 30, 2018 | 1.92B |
March 31, 2018 | 2.455B |
December 31, 2017 | 2.793B |
Date | Value |
---|---|
September 30, 2017 | 2.689B |
June 30, 2017 | 3.747B |
March 31, 2017 | 3.279B |
December 31, 2016 | 3.384B |
September 30, 2016 | 3.022B |
June 30, 2016 | 3.656B |
March 31, 2016 | 7.483B |
December 31, 2015 | 4.079B |
September 30, 2015 | 3.372B |
June 30, 2015 | 4.277B |
March 31, 2015 | 4.263B |
December 31, 2014 | 5.00B |
September 30, 2014 | 4.677B |
June 30, 2014 | 4.745B |
March 31, 2014 | 4.047B |
December 31, 2013 | 3.98B |
September 30, 2013 | 5.138B |
June 30, 2013 | 4.652B |
March 31, 2013 | 4.487B |
December 31, 2012 | 4.285B |
September 30, 2012 | 3.863B |
June 30, 2012 | 3.46B |
March 31, 2012 | 3.297B |
December 31, 2011 | 3.418B |
September 30, 2011 | 3.213B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.127B
Minimum
Jun 2022
7.161B
Maximum
Sep 2020
2.829B
Average
2.312B
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Boston Scientific Corp | 865.00M |
Haemonetics Corp | 193.98M |
Abbott Laboratories | 7.279B |
Edwards Lifesciences Corp | 1.698B |
Zimmer Biomet Holdings Inc | 415.80M |